Literature DB >> 3619652

Factors influencing the caffeine test for cytochrome P 448-dependent liver function.

R Joeres, H Klinker, H Huesler, J Epping, G Hofstetter, D Drost, H Reuss, W Zilly, E Richter.   

Abstract

Liver functions in patients with liver disease can be estimated by caffeine clearance. Our data, however, demonstrate the additional influence of factors other than liver disease on the caffeine test. Smoking enhances caffeine clearance in both healthy volunteers and patients with severe hepatic disorders, whereas co-medication with mexiletine strongly inhibits caffeine elimination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619652     DOI: 10.1007/bf00296957

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene.

Authors:  A Aldridge; W D Parsons; A H Neims
Journal:  Life Sci       Date:  1977-10-01       Impact factor: 5.037

2.  Inhibition by idrocilamide of the disposition of caffeine.

Authors:  J L Brazier; J Descotes; N Lery; M Ollagnier; J C Evreux
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

3.  Caffeine: a model compound for measuring liver function.

Authors:  E Renner; H Wietholtz; P Huguenin; M J Arnaud; R Preisig
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

4.  Effect of smoking on caffeine clearance.

Authors:  W D Parsons; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

5.  The clinical pharmacology of mexiletine.

Authors:  N P Campbell; J G Kelly; A A Adgey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

6.  Disposition of caffeine and its metabolites in man.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

7.  Decreased systemic clearance of caffeine due to cimetidine.

Authors:  L J Broughton; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.